Rhythm Pharmaceuticals (RYTM) was a big mover on higher-than-average trading volume in the most recent session. However, a recent downward trend in earnings estimate revisions is cited as a headwind that could limit the stock's near-term upside.
Rhythm Pharmaceuticals (RYTM) was a big mover on higher-than-average trading volume in the most recent session. However, a recent downward trend in earnings estimate revisions is cited as a headwind that could limit the stock's near-term upside.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
